After phase III flop for Toca 511 and Toca FC, Tocagen slashes 65% of its Workforce. The company stated that it would restructure its staff and operations with the remaining … Continue Reading After Phase III Clinical Trial, Tocagen Axes 65% of its Staff
It was recently discovered that Zantac products might contain a carcinogen that goes by the name N-nitrodimethylamine (NDMA). This carcinogen includes a low level of nitrosamine which is known to … Continue Reading Zantac and Other Antacids Recall For A Carcinogen
With science and technology advancing every day, new discoveries are also being made in the medicine world. Medical Scientists are working on new drugs that are more powerful and act … Continue Reading RNA Delivery May Bring Stronger Vaccines
Melanoma, common skin cancer, was considered to be untreatable a decade ago. Only one in twenty people after being diagnosed with last stage melanoma would live past five years. But … Continue Reading Opdivo and Yervoy Has 5 Year Success Rate for 50% of Melanoma Patients
It seems that more scientists are becoming entrepreneurs, a trend that is growing rapidly within our industry. To help the cause, Deerfield management in New York announced its investment of … Continue Reading New York Invests $635 Million to Attract the Next Generation of Biotech Entrepreneurs
There is no known treatment or cure for the well-known disease, Lou Gehrig’s disease. The disease, commonly known as ALS (Amyotrophic Lateral Sclerosis) causes the death of neurons controlling voluntary muscles.
Dr. Tariq Rana and his colleagues discover a clue in stopping HIV cells from reproducing. A critical cellular player that controls HIV reproduction may be the key. What is HIV? … Continue Reading Can We Stop Infected HIV Cells from Replicating?
Introduction: In 2017, Teva faced claims that the company had violated its patent by pushing doctors to prescribe GlaxoSmithKline’s generic Coreg. This led to a fine of $235 million, for … Continue Reading Teva’s Patent Infringement Surprises Judge
Back in 2017, there were various claims that Teva had violated its patents by inducing doctors to prescribe a generic of Teva similar to a Coreg of GlaxoSmithKline’s and was … Continue Reading Teva’s Patent Infringement Surprises Judge
Ginkgo Bioworks has managed to raise more than $290 million for a cell reprogramming platform. The possibilities are there but they face some challenges. . The primary focus of Ginkgo … Continue Reading Ginkgo raises $290 million in Series E funding for Bioengineering
AstraZeneca has become quite successful locally, but now they are trying to expand in China. They acquire Chinese rights to Ironwood Pharmaceuticals Linzess. A widely sought after product in China, … Continue Reading AstraZeneca partners up with Ironwood for Linzess market in China
Medixci is constantly trying to provide top of the line solutions in order to help drug hunters and biopharma entrepreneurs. This is a very powerful industry and it has the … Continue Reading Medixci Raises $400 Million for Next Drug Hunters and Biotech Entrepreneurs
After ten months since their announcement last November, the London-based company DeepMind Technologies has been taken over by Google. The Takeover Along with this takeover of DeepMind Technologies, the National … Continue Reading DeepMind Health Under Google: Patient Data Out in the Open?
Treatment for cancer patients has come a long way in the past fifty years. Gone are the days when decisions were made based on a hit-or-miss response; the 21st century … Continue Reading Roche’s Tecentriq is Looking Good with Two More Drug Approvals in Europe
Vertex Pharmaceuticals has directed their attention towards gene therapy and stem cell startups. What is Gene therapy? Gene therapy is the effective removal and replacement of a defective genome from … Continue Reading Vertex Pharmaceuticals has a Thing for Genetic Engineering Start Ups
1. Background: uBiome was one of the top five incubations that emerged from the Bay Area. During its first year, the company raised $83 million, and as of January this … Continue Reading After Raid uBiome Files for Bankruptcy